Supply Pharmaceutical Raw Material Powder Misoprostol/Misoprostil CAS 59122-46-2

• Powder: Yes
• Customized: Customized
• Certification: GMP, ISO 9001, USP, BP
• Suitable for: Elderly, Adult
• State: Powder
• Purity: >98%
• Model NO.: TGY2022072601
• Product Name: Misoprostol
• Appearance: White Powder
• Molecular Formula: C22h38o5
• MW: 382.54
• Certificate: ISO 9001, USP
• Shelf Life: 24 Months
• Storage: Cool Dry Area
• Grade: Pharmaceutical Grade
• CAS No.: 59122-46-2
• Sample: Avaliable
• Service: OEM
• MOQ: 20g
• Assay: 98%Min, 99% HPLC
• Test Method: USP;GMP
• COA: Avaliable
• Transport Package: Boil Bag
• Specification: HPLC 99%
• Trademark: TGY
• Origin: Xi′an, Shaanxi, China (Mainland)
• HS Code: 29329990
• Production Capacity: 800kg/Month

Product Description

Product Name	Misoprostol/Misoprostil
CAS No.	59122-46-2
Molecular Formula	C22H38O5
Molecular Weight	382.54
Appearance	White Powder
Assay	99%
Grade	Pharmaceutical Grade

What is Misoprostol?
Misoprostol is a synthetic steroid with antiprogestational effects indicated for the medical termination of intrauterine pregnancy through 49 days' pregnancy. Doses of 1 mg/kg or greater of mifepristone have been shown to antagonize the endometrial and myometrial effects of progesterone in women. During pregnancy, the compound sensitizes the myometrium to the contraction-inducing activity of prostaglandins. Mifepristone also exhibits antiglucocorticoid and weak antiandrogenic activity. The activity of the glucocorticoid  in rats was inhibited following doses of 10 to 25 mg/kg of mifepristone. Doses of 4.5 mg/kg or greater in human beings resulted in a compensatory elevation of adrenocorticotropic hormone and cortisol.

Specification of Misoprostol :

Ref. Standard	According to enterprise internal control standard inspection
Results Of Analysis Tests
Test	Analysis Standard	Results
Description	Light Yellowish Crystalline Powder	Light Yellowish Crystalline Powder
Identification	(1)304nm,260nm.	confirmed
Melting Point	192°C~196°C	192°C~196°C
Specific Rotation	+124°~ +129°	+127.1°
(HPLC) Related substances	(1)(Single):≤0.5%	0.31%
	(2)(Total):≤1.0%	0.59%
Loss On Drying	≤0.5%	0.1%
Assay	≥98.5%	99.5%
Sieve analysis	≤30μm	confirmed
Conclusion	This product conforms to enterprise internal control standards

The first chemically synthesized prostaglandin E1 anti-ulcer drug, which has a strong inhibitory effect on gastric acid secretion and prevents ulcer formation. The gastric acid that can be inhibited includes basal gastric acid secretion and stimulation caused by histamine pentagastrin, food or coffee. It also reduces gastric acid secretion at night. It is the earliest anti-peptic ulcer drug used in clinical practice. It is better than the receptor antagonists for prolonging the recurrence of ulcers, but the effect of alleviating the pain of peptic ulcers is not as good as that of the island receptor antagonists. For gastric and duodenal ulcers, especially in cases with low prostaglandin levels.

For gastric and duodenal ulcers, hemorrhagic gastritis, acute gastric mucosal lesions and other diseases.